What is the translation of " RESPONSE AND TOLERABILITY " in Croatian?

• odgovoru i podnošljivosti

Examples of using Response and tolerability in English and their translations into Croatian

Dose escalation should be based upon clinical response and tolerability.
Povećanje doze mora se temeljiti na kliničkom odgovoru i podnošljivosti.

Depending upon the clinical response and tolerability, the dose can be increased up to 30 mg/kg twice daily.
Ovisno o kliničkom odgovoru i podnošljivosti lijeka, doza se može povećati do 30 mg/kg dva puta na dan.

The dose may be increased to 6 mg once daily based on clinical response and tolerability.
Doza se može povećati na 6 mg jedanput na dan ovisno o kliničkom odgovoru i toleranciji.

Depending upon the clinical response and tolerability, the daily dose can be increased up to 1,500 mg twice daily.
Ovisno o kliničkom odgovoru i podnošljivosti lijeka, dnevna doza može se povećati do 1500 mg dva puta na dan.

Dose should be individualised according to the patient's response and tolerability.
Doza treba biti prilagođena pojedinom bolesniku sukladno odgovoru i podnošljivosti kod bolesnika.

Additionally, patient response and tolerability should be carefully monitored and dose should be adapted accordingly.
Dodatno, treba oprezno pratiti odgovor bolesnika i podnošljivost te sukladno tome prilagoditi dozu.

Dose increase or reduction is recommended based on patient response and tolerability.
Preporučuje se povećanje ili smanjenje doze na temelju kliničkog odgovora bolesnika i podnošljivosti lijeka.

Depending on the clinical response and tolerability in the individual patient, the dose can be increased to 10 mg twice daily.
Ovisno o kliničkom odgovoru i podnošljivosti u pojedinog bolesnika, doza se može povećati na 10 mg dvaput na dan.

The dose can be increased to 10 mg twice daily based on individual clinical response and tolerability.
Na temelju individualnog kliničkog odgovora i podnošljivosti, doza se može povećati na 10 mg dvaput na dan.

Based on individual patient response and tolerability, the dose may be increased to 300 mg(15 ml) per day after 1 week.
Ovisno o odgovoru i podnošljivosti lijeka u pojedinog bolesnika, doza se nakon tjedan dana može povećati na 300 mg(15 ml) na dan.

Dose increases in patients with mild and moderate hepatic impairment should be based on clinical response and tolerability.
Povećanja doze u bolesnika s blagim i umjerenim oštećenjem funkcije jetre treba temeljiti na kliničkom odgovoru i podnošljivosti.

Depending on the patient's response and tolerability for Intuniv the recommended maintenance dose range is 0.05-0.12 mg/kg/day.
Ovisno o bolesnikovu odgovoru i podnošljivosti Intuniva, raspon preporučene doze održavanja iznosi 0, 05-0, 12 mg/kg na dan.

Dosing intervals should be modified according to clinical response and tolerability see sections 4.2 and 4.4.
Intervale doziranja treba prilagoditi prema kliničkom odgovoru i podnošljivosti vidjeti dijelove 4.2 i 4.4.

Based on individual patient response and tolerability, the dose may be adjusted in the dose range of 50 mg/day to 200 mg/day.
Ovisno o odgovoru i podnošljivosti lijeka u pojedinog bolesnika, doza se može prilagođavati unutar raspona od 50 mg/dan do 200 mg/dan.

Thereafter, the total daily dose is increased by a maximum of 150 mg every week, according to the individual patient response and tolerability.
Nakon toga, ukupna dnevna doza povisuje se svakog tjedna za maksimalno 150 mg, prema individualnom terapijskom odgovoru i podnošljivosti pojedinog bolesnika.

Depending upon individual clinical response and tolerability, the dose may be increased or decreased 2 mg at a time see section 4.2.
Ovisno o kliničkom odgovoru i podnošljivosti u pojedinog bolesnika, doza se može povećavati ili snižavati za 2 mg vidjeti dio 4.2.

In populations where the dose may be increased to 8 mg once daily, the dose increase should be preceded by an evaluation of the individual response and tolerability.
U populacijama kod kojih se doza može povisiti na 8 mg jedanput na dan, prije povišenja doze treba procijeniti odgovor i podnošljivost u pojedinog bolesnika.

Based on drug exposure, pharmacodynamic response and tolerability, a lower dose of Pegasys is not needed in the geriatric patient see section 4.2.
Sudeći prema izloženosti lijeku, farmakodinamičkom odgovoru i podnošljivosti, nije potrebno smanjivati dozu lijeka Pegasys u starijih bolesnika vidjeti dio 4.2.

Consideration may be given to lowering the dose to 12.5mg in patients experiencing severe gastrointestinal adverse events depending upon the response and tolerability of individual patients.
U bolesnika u kojih se pojave teški gastrointestinalni štetni događaji može se razmotriti smanjenje doze na 12, 5 mg, sukladno odgovoru i podnošljivosti pojedinih bolesnika.

If concomitant use is warranted, patient response and tolerability should be monitored and dose adjustments made if required see section 4.2.
Ako je istodobna primjena opravdana, treba pratiti odgovor bolesnika i podnošljivost te sukladno tome ako treba prilagoditi dozu vidjeti dio 4.2.

The combination of trazodone with indinavir/ritonavir should be used with caution, initiating trazodone at the lowest dose and monitoring for clinical response and tolerability.
Kombinaciju trazodona i indinavira/ritonavira treba primjenjivati uz oprez, započinjući liječenje trazadonom u najnižoj dozi te prateći klinički odgovor i podnošljivost.

Caution should be exercised and careful assessment of therapeutic response and tolerability should be made before increasing to daily dosing after one week.
Potreban je oprez, a pažljiva ocjena terapijskog odgovora i podnošljivosti treba se učiniti prije povišenja na dnevno doziranje nakon jednog tjedna.

Depending on response and tolerability, the maintenance dose can be further increased by 50 mg twice a day every week, to a maximum recommended daily dose of 400 mg 200 mg twice a day.
Ovisno o odgovoru i podnošljivosti, doza održavanja se svakih tjedan dana može povećavati za 50 mg dvaput na dan do maksimalne preporučene dnevne doze od 400 mg 200 mg dvaput na dan.

If trazodone is co- administered with ritonavir, the combination should be used with caution, initiating trazodone at the lowest dosage and monitoring for clinical response and tolerability.
Ako se trazodon daje istodobno s ritonavirom, tu kombinaciju treba davati oprezno, a trazodon treba početi davati u najmanjoj dozi te pratiti klinički odgovor i podnošljivost.

Depending on response and tolerability, Vimpat 150 mg tablets may be taken twice a day during the third week and Vimpat 200 mg tablets twice a day during the fourth week.
Ovisno o odgovoru i podnošljivosti, Vimpat tablete od 150 mg mogu se uzimati dvaput na dan tijekom trećeg tjedna i Vimpat tablete od 200 mg dvaput na dan tijekom četvrtog tjedna.

Vimpat treatment initiation pack contains 4 different packages(one for each tablet strength) with 14 tablets each, for the first 2 to 4 weeks of therapy depending on the patient's response and tolerability.
Vimpat pakiranje za početak liječenja sadrži 4 različita pakiranja(jedno za svaku jačinu tablete), svako s 14 tableta, za prva 2 do 4 tjedna terapije ovisno o odgovoru i podnošljivosti bolesnika.

According to clinical response and tolerability, the dose may be increased by 400 mg/day increments, as frequently as every two days, up to a maximum recommended dose as indicated in the table below.
Sukladno kliničkom odgovoru i podnošljivosti, doza se može povećavati za 400 mg na dan, najviše svaka dva dana, do maksimalne preporučene dnevne doze kako je navedeno u tablici niže.

The total daily starting dose is 150 mg/day and during the titration period the total daily dose should be increased by a maximum of 150 mg every week, according to the individual patient response and tolerability.
Ukupna dnevna početna doza je 150 mg/dan, te se tijekom titracijskog razdoblja prema individualnom terapijskom odgovoru i podnošljivosti bolesnika treba povisiti svakog tjedna za najviše 150 mg.

Based on individual patient response and tolerability, the dose may be increased to 300 mg(15 ml) per day after an interval of 3 to 7 days, and if needed, to a maximum dose of 600 mg(30 ml) per day after an additional 7-day interval.
Ovisno o odgovoru i podnošljivosti lijeka u pojedinog bolesnika, doza se nakon razdoblja od 3 do 7 dana može povećati na 300 mg(15 ml) na dan te, po potrebi, nakon dodatnih 7 dana na maksimalnu dozu od 600 mg(30 ml) na dan.

However, this increase is not considered to be clinically meaningful, and since retigabine is titrated according to individual patient response and tolerability, dose-adjustments are not required on the basis of body weight.
Međutim, ne smatra se da taj porast ima kliničko značenje, a kako se retigabin titrira prema individualnom odgovoru i podnošljivosti bolesnika, prilagodbe doza prema tjelesnoj težini nisu potrebne.